Pharma Focus America

LATEST NEWSRead more...

12

Jul 2024

Rentschler Biopharma's New Advanced Production Line in Massachusetts Now Fully Operational

Rentschler Biopharma SE a leading global contract development and manufacturing organization specializing in biopharmaceuticals and advanced therapy

12

Jul 2024

Thermo Fisher Scientific to Advance Myeloid Cancer Research and Treatment Using Next Generation Sequencing Technology

Thermo Fisher Scientific Inc a leader in scientific solutions has partnered with the National Cancer Institute to launch myeloMATCH a precision medicine umbrella trial aimed at accelerating research

12

Jul 2024

Senhwa Biosciences Submits IND to FDA for Phase I/II Trial of Silmitasertib (CX-4945) in Pediatric and Young Adult Patients with Relapsed Refractory Solid Tumors

Senhwa Biosciences Inc has submitted an Investigational New Drug application to the US FDA for a Phase III study of Silmitasertib combined with chemotherapy in children and young adults

11

Jul 2024

Spine BioPharma, Inc. and Ensol BioSciences, Inc. have reached an agreement to broaden the applications of SB-01 For Injection

Spine BioPharma Inc a company focused on developing nonopioid nonsurgical therapies for painrelated disabilities has announced a significant agreement with Ensol BioSciences Inc a Korean company

11

Jul 2024

Cosette Pharmaceuticals Finalizes Acquisition of Ambien® and Ambien CR® (Zolpidem Tartrate) Tablets from Sanofi US

Cosette Pharmaceuticals a USbased specialty pharmaceutical company has completed the acquisition of Ambien and Ambien CR in the United States from Sanofi US

10

Jul 2024

Aspect Biosystems Partners with Canadian and British Columbia Governments for $200 Million Initiative to Advance Bioprinted Tissue Therapeutics

Aspect Biosystems a prominent biotechnology company specializing in bioprinted tissue therapeutics has received a substantial million investment from the Governments of Canada

press releasesRead more...

Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer

CanFite BioPharma Ltd a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases today announced that it has submitted

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

Satellos Bioscience Inc a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders today announced submission

FDA Approved PDE4 Inhibitor Roflumilast for Atopic Dermatitis

On July th the US FDA approved Arcutis Biotherapeutics ZORYVE roflumilast for treating atopic dermatitis AD the most common type of eczema affecting millions in the US This oncedaily steroidfree cream could become a new standard of care for AD The approval underscores the growing importance of res...

Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers

Prelude Therapeutics Incorporated a clinicalstage precision oncology company today announced that it has entered into a clinical trial collaboration and supply

18 - 20

Jul 2024

Pharma India Expo 2024

Telangana, India

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues